Browsing: lung cancer

AstraZeneca and Qure.ai’s AI-enabled chest X-ray program has identified 50,000 individuals at high risk for lung cancer across 20 countries, enhancing early detection in resource-limited settings.

Researchers at Amsterdam UMC have developed an AI algorithm that can help GPs identify lung cancer patients up to 4 months earlier than current methods.

Johnson & Johnson MedTech’s Monarch Quest technology, featuring AI-powered algorithms, receives FDA clearance for robotic-assisted bronchoscopy, promising enhanced accuracy and early lung cancer diagnoses.

VeGen Labs, a biotechnology startup based at the University of Hyderabad, has secured significant funding to advance its research towards a KRAS inhibitor for the treatment of non-small cell lung cancer.